Protagonist Therapeutics, Inc (PTGX) /
The profitability of Protagonist Therapeutics, Inc over the past 10 years
Chart Protagonist Therapeutics, Inc: operating income, net income, fiscal 2016–2025 Open the chart →Protagonist Therapeutics, Inc reported a net loss of $130.15M in fiscal 2025, the latest fiscal year on file. That year it had an operating loss of $158.13M. It reported a profit in 1 of the 10 years shown, and a loss in fiscal 2016, 2017, 2018, 2019, 2020, 2021, 2022, 2023 and 2025. Its highest net income in these years was $275.19M, in fiscal 2024.
Year by year
| Fiscal year | Operating income | Net income |
|---|---|---|
| 2025ended Dec 31, 2025 | -$158.13M | -$130.15M |
| 2024ended Dec 31, 2024 | $252.84M | $275.19M |
| 2023ended Dec 31, 2023 | -$93.65M | -$78.95M |
| 2022ended Dec 31, 2022 | -$131.37M | -$127.39M |
| 2021ended Dec 31, 2021 | -$125.84M | -$125.55M |
| 2020ended Dec 31, 2020 | -$64.52M | -$66.15M |
| 2019ended Dec 31, 2019 | -$80.52M | -$77.19M |
| 2018ended Dec 31, 2018 | -$42.27M | -$38.92M |
| 2017ended Dec 31, 2017 | -$37.9M | -$36.96M |
| 2016ended Dec 31, 2016 | -$32.67M | -$37.18M |
Fiscal years as Protagonist Therapeutics, Inc reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Protagonist Therapeutics, Inc
- The revenue of Protagonist Therapeutics, Inc
- The cash flow of Protagonist Therapeutics, Inc
- The debt of Protagonist Therapeutics, Inc
- All of Protagonist Therapeutics, Inc's financials, charted
Companies of a similar size
Not investment advice. This page shows what Protagonist Therapeutics, Inc filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.